Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1533160
Max Phase: Preclinical
Molecular Formula: C12H13N3O5S
Molecular Weight: 311.32
Molecule Type: Small molecule
Associated Items:
ID: ALA1533160
Max Phase: Preclinical
Molecular Formula: C12H13N3O5S
Molecular Weight: 311.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)C1CCN(S(=O)(=O)c2cccc3nonc23)CC1
Standard InChI: InChI=1S/C12H13N3O5S/c16-12(17)8-4-6-15(7-5-8)21(18,19)10-3-1-2-9-11(10)14-20-13-9/h1-3,8H,4-7H2,(H,16,17)
Standard InChI Key: JDSKNNBTAUKETK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 311.32 | Molecular Weight (Monoisotopic): 311.0576 | AlogP: 0.71 | #Rotatable Bonds: 3 |
Polar Surface Area: 113.60 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.03 | CX Basic pKa: | CX LogP: 0.45 | CX LogD: -2.69 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.89 | Np Likeness Score: -1.99 |
1. PubChem BioAssay data set, |
Source(1):